Related Experiment Videos
[Hepatic diseases caused by drugs]
Praxis
|July 16, 1997
Summary
Drug-induced liver injury presents diverse clinical and pathological forms, stemming from intrinsic toxicity or immune responses. Early drug withdrawal is key for managing drug-induced hepatotoxicity and preventing chronic liver damage.
Area of Science:
- Hepatology
- Toxicology
- Immunology
Background:
- Drug-induced hepatotoxicity encompasses a wide spectrum of acute and chronic liver diseases.
- Liver damage mechanisms include intrinsic drug toxicity (e.g., paracetamol) and immunoallergic reactions (e.g., halothane).
Purpose of the Study:
- To review the clinical and pathological manifestations of drug-induced liver injury.
- To outline diagnostic approaches and treatment strategies for drug-induced hepatotoxicity.
Main Methods:
- Review of clinical and pathological presentations of drug-induced liver diseases.
- Analysis of diagnostic criteria including drug history, temporal relationship, and exclusion of other causes.
- Discussion of treatment modalities, focusing on drug withdrawal and specific antidotes.
Main Results:
- Acute liver injury can be cytotoxic (necrosis, steatosis) or cholestatic (immune-mediated or transport inhibition).
- Chronic manifestations include hepatitis, fibrosis, cholestatic diseases, vascular lesions, and neoplasms.
- Diagnosis relies on comprehensive patient history and exclusion of alternative etiologies.
Conclusions:
- Drug-induced liver diseases often present nonspecifically, necessitating careful evaluation.
- Prompt drug cessation is crucial for reversibility; prolonged exposure can lead to cirrhosis.
- Management involves immediate withdrawal of the offending agent and supportive care, with specific antidotes like acetylcysteine for paracetamol overdose.